discovery of neurotrophins small molecule mimetics
small molecule neurotrophin mimetics
novel small molecule
ND pathogenesis
European training network
development of new ND treatments
therapeutic potential of neurotrophins
steps of drug discovery
promising effects of small neurotrophin mimetics
collaborative training
doctoral training
deep understanding of neurotrophins
European consortium
poor pharmacokinetic properties of neurotrophins
unique training programme
use
translation of identified drug candidate molecules
candidate therapeutic agents
leading European research groups
novel therapies
key specialists
skilled researchers
available drugs
stage researchers
clinical translation
drugs prohibitive
key idea
results of beneficiaries NHRF
neurodegeneration
favourable profiles of stability
tissue penetration
neuroinflammation Neurodegenerative diseases
private companies of complementary expertise
depth
MND
ALS
survival
single academic institution
PD
neuroprotection
targeted biological actions
necessary skills
rise
MS
previous successful collaborations
market
limitation
neurogenesis
number of aspects
function of neurons
project
Preclinical studies
molecular probes
need
developed societies
approach
EuroNeurotrophin
cure